Quinazolinone-dihydropyrano[3,2-b]pyran hybrids as new α-glucosidase inhibitors: Design, synthesis, enzymatic inhibition, docking study and prediction of pharmacokinetic

被引:17
|
作者
Sherafati, Maedeh [1 ]
Mirzazadeh, Roghieh [2 ]
Barzegari, Ebrahim [3 ]
Mohammadi-Khanaposhtani, Maryam [4 ]
Azizian, Homa [5 ]
Asgari, Mohammad Sadegh [6 ]
Hosseini, Samanesadat [7 ]
Zabihi, Ebrahim [4 ]
Mojtabavi, Somayeh [8 ]
Faramarzi, Mohammad Ali [8 ]
Mahdavi, Mohammad [1 ]
Larijani, Bagher [1 ]
Rastegar, Hossein [9 ]
Hamedifar, Haleh [10 ]
Hajimiri, Mir Hamed [11 ]
机构
[1] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran
[2] Pasteur Inst Iran, Dept Biochem, Tehran, Iran
[3] Kermanshah Univ Med Sci, Med Biol Res Ctr, Hlth Technol Inst, Kermanshah, Iran
[4] Babol Univ Med Sci, Cellular & Mol Biol Res Ctr, Hlth Res Inst, Babol, Iran
[5] Iran Univ Med Sci, Sch Pharm, Dept Med Chem, Tehran, Iran
[6] Iran Univ Sci & Technol, Dept Chem, Tehran, Iran
[7] Shahid Beheshti Univ Med Sci, Sch Pharm, Dept Pharmaceut Chem, Tehran, Iran
[8] Univ Tehran Med Sci, Fac Pharm, Dept Pharmaceut Biotechnol, Tehran, Iran
[9] Iranian Food & Drug Adm, Cosmet Prod Res Ctr, MOHE, Tehran, Iran
[10] Alborz Univ Med Sci, CinnaGen Med Biotechnol Res Ctr, Karaj, Iran
[11] Univ Tehran Med Sci, Nano Alvand Co, Avicenna Tech Pk, Tehran, Iran
关键词
-Glucosidase; Quinazolinone-dihydropyrano[3; 2-b]pyran; hybrids; -Amylase; Type; 2; diabetes; Docking study; Pharmacokinetic prediction; DERIVATIVES; AGENTS;
D O I
10.1016/j.bioorg.2021.104703
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of new quinazolinone-dihydropyrano[3,2-b]pyran derivatives 10A-L were synthesized by simple chemical reactions and were investigated for inhibitory activities against ?-glucosidase and ?-amylase. New synthesized compounds showed high ?-glucosidase inhibition effects in comparison to the standard drug acarbose and were inactive against ?-amylase. Among them, the most potent compound was compound 10L (IC50 value = 40.1 ? 0.6 ?M) with inhibitory activity around 18.75-fold more than acarboase (IC50 value = 750.0 ? 12.5 ?M). This compound was a competitive inhibitor into ?-glucosidase. Our obtained experimental results were confirmed by docking studies. Furthermore, the cytotoxicity of the most potent compounds 10L, 10G, and 10N against normal fibroblast cells and in silico druglikeness, ADME, and toxicity prediction of these compounds were also evaluated.
引用
收藏
页数:10
相关论文
共 23 条
  • [1] Synthesis and Biological Evaluation of New Dihydrofuro[3,2-b]piperidine Derivatives as Potent α-Glucosidase Inhibitors
    Wang, Haibo
    Huang, Xiaojiang
    Pan, Yang
    Zhang, Guoqing
    Tang, Senling
    Shao, Huawu
    Jiao, Wei
    MOLECULES, 2024, 29 (05):
  • [2] Design and synthesis of new benzylidene-quinazolinone hybrids as potential anti-diabetic agents: In vitro α-glucosidase inhibition, and docking studies
    Khalifa, Mohamed M.
    Sakr, Helmy M.
    Ibrahim, Albaraa
    Mansour, Ahmed M.
    Ayyad, Rezk R.
    JOURNAL OF MOLECULAR STRUCTURE, 2022, 1250
  • [3] Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study
    Saeedi, Mina
    Mohammadi-Khanaposhtani, Maryam
    Pourrabia, Parvaneh
    Razzaghi, Nima
    Ghadimi, Reza
    Imanparast, Somaye
    Faramarzi, Mohammad Ali
    Bandarian, Fatemeh
    Esfahani, Ensieh Nasli
    Safavi, Maliheh
    Rastegar, Hossein
    Larijani, Bagher
    Mandavi, Mohammad
    Akbarzadeh, Tahmineh
    BIOORGANIC CHEMISTRY, 2019, 83 : 161 - 169
  • [4] Design and synthesis of new imidazo[1,2-b]pyrazole derivatives, in vitro α-glucosidase inhibition, kinetic and docking studies
    Peytam, Fariba
    Adib, Mehdi
    Shourgeshty, Reihaneh
    Mohammadi-Khanaposhtani, Maryam
    Jahani, Mehdi
    Imanparast, Somaye
    Faramarzi, Mohammad Ali
    Mahdavi, Mohammad
    Moghadamnia, Ali Akbar
    Rastegar, Hossein
    Larijani, Bagher
    MOLECULAR DIVERSITY, 2020, 24 (01) : 69 - 80
  • [5] Design and synthesis of new imidazo[1,2-b]pyrazole derivatives, in vitro α-glucosidase inhibition, kinetic and docking studies
    Fariba Peytam
    Mehdi Adib
    Reihaneh Shourgeshty
    Maryam Mohammadi-Khanaposhtani
    Mehdi Jahani
    Somaye Imanparast
    Mohammad Ali Faramarzi
    Mohammad Mahdavi
    Ali Akbar Moghadamnia
    Hossein Rastegar
    Bagher Larijani
    Molecular Diversity, 2020, 24 : 69 - 80
  • [6] The clean synthesis and confirmatory structural characterization of new 2-amino-4,8-dihydropyrano[3,2-b]pyran-3-cyano based on Kojic acid
    Aghbash, Khadijeh Ojaghi
    Pesyan, Nader Noroozi
    Notash, Behrouz
    MONATSHEFTE FUR CHEMIE, 2018, 149 (11): : 2059 - 2067
  • [7] The clean synthesis and confirmatory structural characterization of new 2-amino-4,8-dihydropyrano[3,2-b]pyran-3-cyano based on Kojic acid
    Khadijeh Ojaghi Aghbash
    Nader Noroozi Pesyan
    Behrouz Notash
    Monatshefte für Chemie - Chemical Monthly, 2018, 149 : 2059 - 2067
  • [8] New phthalimide-benzamide-1,2,3-triazole hybrids; design, synthesis, α-glucosidase inhibition assay, and docking study
    Sadat-Ebrahimi, Seyed Esmaeil
    Rahmani, Abbas
    Mohammadi-Khanaposhtani, Maryam
    Jafari, Negar
    Mojtabavi, Somayeh
    Faramarzi, Mohammad Ali
    Emadi, Mehdi
    Yahya-Meymandi, Azadeh
    Larijani, Bagher
    Biglar, Mahmoud
    Mahdavi, Mohammad
    MEDICINAL CHEMISTRY RESEARCH, 2020, 29 (05) : 868 - 876
  • [9] New phthalimide-benzamide-1,2,3-triazole hybrids; design, synthesis, α-glucosidase inhibition assay, and docking study
    Seyed Esmaeil Sadat-Ebrahimi
    Abbas Rahmani
    Maryam Mohammadi-Khanaposhtani
    Negar jafari
    Somayeh Mojtabavi
    Mohammad Ali Faramarzi
    Mehdi Emadi
    Azadeh Yahya-Meymandi
    Bagher Larijani
    Mahmoud Biglar
    Mohammad Mahdavi
    Medicinal Chemistry Research, 2020, 29 : 868 - 876
  • [10] Synthesis, Antioxidant, Cytotoxicity, Induce Apoptosis Investigation and Docking Study of New Halogenated Dihydropyrano[3,2-b]Chromene-3-Carbonitrile Derivatives on MCF-7 Breast Cancer Cell Line
    Eslaminejad, Touba
    Mirzaei, Ehsan Faghih
    Abaszadeh, Mehdi
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2023, 22 (01):